SOPHiA GENETICS
SOPH
SOPH
34 hedge funds and large institutions have $54.7M invested in SOPHiA GENETICS in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1.29% less ownership
Funds ownership: 33.77% → 32.48% (-1.3%)
22% less capital invested
Capital invested by funds: $70.4M → $54.7M (-$15.7M)
Holders
34
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.45M | |
| 2 | +$1.32M | |
| 3 | +$794K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$204K |
| 5 |
PVI
Pura Vida Investments
New York
|
+$127K |
Top Sellers
| 1 | -$3.45M | |
| 2 | -$3.11M | |
| 3 | -$209K | |
| 4 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$91.9K |
| 5 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
-$59.6K |